COMMD5 and invasive breast carcinoma: We also found that several shallow deletions and some deep deletions correlated with COMMD5 mRNA downregulation and this is more pronounced in breast invasive carcinoma, colorectal, lung and renal cancer including ccRCC and chromophobe RCC (Figure 4A).